Bayer CropScience Q1 FY27: Profit Up 15%, Revenue Down 4%
BAYERCROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.0 pts less than Nifty Smallcap 250 and 1.2 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Q1 FY27 revenue from operations fell 4% to Rs 18,350 mn versus Rs 19,146 mn a year ago. However, total expenses dropped nearly 5% to Rs 15,218 mn, lifting profit before tax 20% to Rs 4,021 mn. Net profit grew 15% to Rs 3,216 mn, with EPS at Rs 71.56 versus Rs 62.01. Other income includes a Rs 639 mn gain from divesting marketing rights for formulated products. Auditor Deloitte issued an unqualified limited review report.
Softer top line but tighter costs expanded margins, lifting profit. Clean audit report supports steady earnings.